Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells

Experimental Hematology

Volumn 34, Issue 11, 2006, Pages 1583-1587

  Yannaki, Evangelia ^a   Anagnostopoulos, Achilles ^a   Kapetanos, Demetrios ^a   Xagorari, Angeliki ^a   Iordanidis, Fotis ^a   Batsis, Ioannis ^a   Kaloyannidis, Panayotis ^a   Athanasiou, Evangelia ^a   Dourvas, Georgios ^a   Kitis, Georgios ^a   Fassas, Athanasios ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; DISEASE COURSE; FOLLOW UP; HUMAN; LEUKAPHERESIS; LIVER REGENERATION; MALE; PATIENT SAFETY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TREATMENT RESPONSE;

BIOPSY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECOVERY OF FUNCTION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33749635475     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.06.012     Document Type: Article

References (23)

1. Brazelton T.R., Rossi F.M., Keshet G.I., and Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290 (2000) 1775-1779
2. Krause D., Theise N., Collector M., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
3. Ianus A., Holz G., Theise N., and Hussain M. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111 (2003) 843-850
4. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 284 (1999) 1168-1170
5. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6 11 (2000) 1229-1234
6. Vassilopoulos G., Wang P., and Russell D. Transplanted bone marrow regenerates liver by cell fusion. Nature 422 (2003) 901-904
7. Yannaki E., Athanasiou E., Xagorari A., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 33 (2005) 108-119
8. Theise N., Nimmakayalu M., Gardner R., et al. Liver from bone marrow in humans. Hepatology 32 (2000) 11-16
9. Korbling M., Katz R.L., Khanna A., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346 (2002) 738-746
10. Alison M.R., Poulsom R., Jeffery R., et al. Hepatocytes from non-hepatic adult stem cells. Nature 406 (2000) 257
11. Picardi M., De Roza G., Selleri C., et al. Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. Haematologica 88 7 (2003) 794-800
12. Becker P.S., Wagle M., Matous S., et al. Spontaneous splenic rupture following administration of granulocyte-colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of periperal blood stem cells. Biol Blood Marrow Transplant 3 6 (1997) 341-343
13. Gaia S., Smedile A., Omede P., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol 45 (2006) 13-19
14. Huo T.-I., Lin H.-C., Lee F.-Y., et al. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score. Liver Int 26 (2005) 55-61
15. Kamath P., Wiesner R., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 2 (2001) 464-470
16. Giron-González J.A., Martínez-Sierra C., Rodriguez-Ramos C., et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 24 (2004) 437-445
17. Genesca J., Gonzalez A., Segura R., et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol 94 1 (1999) 169-177
18. Hartung T., Docke W.-D., Gantner F., et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85 9 (1995) 2482-2489
19. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114 3 (2004) 330-338
20. Lee S.-T., Chu K., Jung K.-H., et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal celebral ischemia. Brain Res 1058 (2005) 120-128
21. Minamino K., Adachi Y., Okigaki M., et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells 23 3 (2005) 347-354
22. Shimizu H., Miyazaki M., Wakabayashi Y., et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 34 (2001) 683-689
23. Reynaert H., Chavez M., and Geerts A. Vascular endothelial growth factor and liver regeneration. J Hepatol 34 (2001) 759-761